C. E. Langan

Assessing patient outcomes in acute exacerbations of chronic bronchitis: The measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D)

Charlotte Paterson, C. E. Langan, G.A. McKaig et al. · Quality of Life Research · 2000 · 83 citations

Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis

C. E. Langan, R. Cranfield, S. Breisch et al. · Journal of Antimicrobial Chemotherapy · 1997 · 62 citations

Grepafloxacin 600, Grepafloxacin Doses, Antimicrobial Susceptibility +15

Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis

Robert Wilson, C. E. Langan, Peter Ball et al. · Respiratory Medicine · 2003 · 42 citations · Full text

Oral Gemifloxacin, Pulmonary Care, Infectious Respiratory Disease +4

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis

C. E. Langan, P. Zück, F. Vogel et al. · Journal of Antimicrobial Chemotherapy · 1999 · 42 citations · Full text

SHORT‐COURSE CEFUROXIME AXETIL THERAPY IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS

C. E. Langan, B Clecner, CM Cazzola et al. · International Journal of Clinical Practice · 1998 · 35 citations · Full text